Use of Home Telehealth Monitoring with Active Medication Therapy Management by Clinical Pharmacists in Veterans with Poorly Controlled Type 2 Diabetes Mellitus
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Study Objective: To compare the effect of medication therapy management by a clinical pharmacy specialist who used the Care Coordination Home Telehealth (CCHT) program with the effect of medication therapy management by a clinical pharmacy specialist who did not use the CCHT program in a cohort of patients with poorly controlled type 2 diabetes mellitus. Design: Nonrandomized, parallel, control group study. Setting: Four outpatient primary care clinics within a Veterans Affairs health care system in which diabetes management services were provided by three clinical pharmacy specialists. Patients: One hundred three patients with type 2 diabetes and a hemoglobin A 1c (A1C) of greater than 7% who were receiving insulin therapy between October 1, 2008, and April 1, 2010; 36 patients were enrolled in the CCHT group, and 67 patients were in the non‐CCHT group. Patients enrolled in the CCHT group were initially seen by a clinical pharmacy specialist and had two follow‐up visits within a 6‐month period. The CCHT program predominantly used a messaging device as a means of communication between providers and clinical pharmacy specialists and patients in the time intervals between their face‐to‐face visits. The clinical pharmacy specialist evaluated the transmitted data and made clinical decisions with respect to medication therapy management and diabetes management; a registered nurse communicated this information to the patients by telephone. Measurements and Main Results: Data from medical records were reviewed for both groups. Baseline demographics were similar between the groups, with an initial A1C of 9% and 9.1% in the CCHT and non‐CCHT groups, respectively (p=0.6201). The primary outcome was the change in A1C from baseline to 6 months. Secondary outcomes included the percentage of patients meeting American Diabetes Association (ADA) treatment goals for A1C, total amount of time spent/patient, and number of antidiabetic drug changes. A statistically significant difference in mean A1C was noted in the CCHT versus the non‐CCHT group at 3 months (7.2% vs 8.0%, p=0.0002) and 6 months (6.9% vs 7.5%, p=0.0066); however, the mean reduction in A1C from baseline to 6 months was not significant between groups (p=0.1987). Sixty‐nine percent of the CCHT group versus 36% in the non‐CCHT group achieved the ADA A1C goal of less than 7% (p=0.0011). More time was spent (p<0.001) and more antidiabetic drug changes were made (p<0.0001) in the CCHT group. Conclusion: Management of patients with diabetes who are receiving insulin may be optimized by clinical pharmacy specialist use of the CCHT program. Although no statistically significant difference was demonstrated with respect to change in A1C from baseline to 6 months, the CCHT group did show significantly greater differences than the non‐CCHT group in A1C at 3 and 6 months, coupled with higher achievement of ADA A1C goals after 6 months.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cranor, C. W., Bunting, B. A., & Christensen, D. B. (2003) · Journal of the American Pharmaceutical Association (1996) · doi:10.1331/108658003321480713 · Cited by 728
Telecare for Patients With Type 1 Diabetes and Inadequate Glycemic Control
Montori, V. M., Helgemoe, P. K., Guyatt, G. H., Dean, D. S., Leung, T. W., Smith, S. A., & Kudva, Y. C. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1088 · Cited by 169
Bergenstal, R. M., Anderson, R. L., Bina, D. M., Johnson, M. L., Davidson, J. L., Solarz-Johnson, B., & Kendall, D. M. (2005) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2005.7.241 · Cited by 37
Cited by
Niznik, J. D., He, H., & Kane-Gill, S. L. (2018) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2017.10.011 · Cited by 189
Powell, R. E., Zaccardi, F., Beebe, C., Chen, X. M., Crawford, A., Cuddeback, J., Gabbay, R. A., Kissela, L., Litchman, M. L., Mehta, R., et al. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14455 · Cited by 99
“While studies included in this review did not consistently report frequency of patient communication between study arms, among those that were effective, several reported that the interventions involved regular inPharmacist-based intervention [I(2), 0%] Al Hamarneh (13) Jameson (27) Tilton (41) Prudencio (37) Care man…”
BackgroundAlvarado, M. M., Kum, H.-C., Gonzalez Coronado, K., Foster, M. J., Ortega, P., & Lawley, M. A. (2017) · Journal of Medical Internet Research · doi:10.2196/jmir.6382 · Cited by 95
“There were 27% (11/41) studies t h a t d i d n o t r e p o r t a d r o p o u t r a t e [23,28,34,38,39,42,44,59,62,65,66].”
Kebede, M. M., Liedtke, T. P., Möllers, T., & Pischke, C. R. (2017) · Journal of Medical Internet Research · doi:10.2196/jmir.7135 · Cited by 69
“[6,32,33,56-58,61,63-73,75,78] 21 “If the sum of all high glycemic index foods in the previous 24-hour period is 5 Natural consequences Information about health consequences (5.”
BackgroundInfluentialTelepharmacy for the management of cardiovascular patients in the community
Omboni, S., & Tenti, M. (2019) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2018.07.002 · Cited by 51
Metadata
- Authors
- McFarland, M., Davis, K., Wallace, J., Wan, J., Cassidy, R., Morgan, T., & Venugopal, D.
- Venue
- Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Publisher
- Wiley
- Published
- 2012-04-09
- Volume
- 32
- Issue
- 5
- Pages
- 420-426
- ISSN
- 0277-0008 (ISSN-L)
- 1875-9114
- OpenAlex
- W2119839346
- Cited by
- 74
- References
- 3
- FWCI
- 6.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.